Amalgamated Bank’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-325
| Closed | -$2K | – | 3026 |
|
|
2025
Q1 | $2K | Sell |
325
-1
| -0.3% | -$6 | ﹤0.01% | 2826 |
|
|
2024
Q4 | $3K | Hold |
326
| – | – | ﹤0.01% | 2831 |
|
|
2024
Q3 | $3K | Hold |
326
| – | – | ﹤0.01% | 2865 |
|
|
2024
Q2 | $6K | Hold |
326
| – | – | ﹤0.01% | 2669 |
|
|
2024
Q1 | $8K | Sell |
326
-125
| -28% | -$3.2K | ﹤0.01% | 2514 |
|
|
2023
Q4 | $12K | Sell |
451
-45
| -9% | -$2.74K | ﹤0.01% | 2828 |
|
|
2023
Q3 | $30K | Hold |
496
| – | – | ﹤0.01% | 2468 |
|
|
2023
Q2 | $33K | Hold |
496
| – | – | ﹤0.01% | 2487 |
|
|
2023
Q1 | $32K | Sell |
496
-50
| -9% | -$5.71K | ﹤0.01% | 2478 |
|
|
2022
Q4 | $76K | Buy |
546
+75
| +16% | +$10.6K | ﹤0.01% | 2250 |
|
|
2022
Q3 | $60K | Buy |
471
+28
| +6% | +$3.17K | ﹤0.01% | 2378 |
|
|
2022
Q2 | $37K | Buy |
443
+36
| +9% | +$2.79K | ﹤0.01% | 2619 |
|
|
2022
Q1 | $39K | Buy |
+407
| New | +$53.7K | ﹤0.01% | 2584 |
|
|
2021
Q3 | – | Sell |
-732
| Closed | -$303K | – | 2167 |
|
|
2021
Q2 | $303K | Sell |
732
-27
| -4% | -$10.7K | ﹤0.01% | 1880 |
|
|
2021
Q1 | $296K | Sell |
759
-54
| -7% | -$26.6K | 0.01% | 1268 |
|
|
2020
Q4 | $456K | Sell |
813
-1
| -0.1% | -$634 | 0.02% | 1019 |
|
|
2020
Q3 | $569K | Buy |
814
+8
| +1% | +$6.24K | 0.02% | 765 |
|
|
2020
Q2 | $638K | Sell |
806
-122
| -13% | -$92K | 0.03% | 679 |
|
|
2020
Q1 | $553K | Sell |
928
-27
| -3% | -$26.3K | 0.01% | 857 |
|
|
2019
Q4 | $1.09M | Buy |
955
+114
| +14% | +$124K | 0.02% | 775 |
|
|
2019
Q3 | $1M | Sell |
841
-11
| -1% | -$16.8K | 0.02% | 744 |
|
|
2019
Q2 | $1.4M | Sell |
852
-53
| -6% | -$91.7K | 0.03% | 607 |
|
|
2019
Q1 | $1.84M | Buy |
905
+18
| +2% | +$31.7K | 0.04% | 424 |
|
|
2018
Q4 | $1.14M | Buy |
887
+250
| +39% | +$383K | 0.03% | 599 |
|
|
2018
Q3 | $1.2M | Sell |
637
-214
| -25% | -$442K | 0.03% | 575 |
|
|
2018
Q2 | $1.73M | Buy |
851
+350
| +70% | +$798K | 0.04% | 460 |
|
|
2018
Q1 | $1.11M | Sell |
501
-9
| -2% | -$22.9K | 0.03% | 659 |
|
|
2017
Q4 | $1.18M | Buy |
510
+67
| +15% | +$136K | 0.03% | 629 |
|
|
2017
Q3 | $788K | Buy |
443
+39
| +10% | +$54.5K | 0.02% | 775 |
|
|
2017
Q2 | $550K | Buy |
404
+13
| +3% | +$15.7K | 0.02% | 906 |
|
|
2017
Q1 | $460K | Hold |
391
| – | – | 0.02% | 884 |
|
|
2016
Q4 | $312K | Buy |
391
+82
| +27% | +$65.1K | 0.01% | 1111 |
|
|
2016
Q3 | $272K | Buy |
309
+1
| +0.3% | +$724 | 0.02% | 1072 |
|
|
2016
Q2 | $222K | Buy |
+308
| New | +$174K | 0.01% | 1197 |
|
|
2016
Q1 | – | Sell |
-301
| Closed | -$250K | – | 1299 |
|
|
2015
Q4 | $250K | Sell |
301
-22
| -7% | -$22K | 0.03% | 907 |
|
|
2015
Q3 | $358K | Buy |
323
+31
| +11% | +$56.5K | 0.04% | 754 |
|
|
2015
Q2 | $636K | Buy |
292
+98
| +51% | +$200K | 0.06% | 405 |
|
|
2015
Q1 | $303K | Buy |
+194
| New | +$256K | 0.04% | 672 |
|
Other funds holding BLUE
Amalgamated Bank's BLUE Position: Q2 2025 in Review
Amalgamated Bank sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 325 shares — an estimated $2K sold.
Amalgamated Bank first reported a position in BLUE in Q1 2015 and held it in 38 quarters. The position peaked at $1.84M in Q1 2019. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Amalgamated Bank reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Amalgamated Bank sold 325 bluebird bio shares in Q2 2025, an estimated $2K.
- Amalgamated Bank first reported a position in bluebird bio in Q1 2015 and held it in 38 quarters.
- Amalgamated Bank's bluebird bio position peaked at $1.84M in Q1 2019.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Amalgamated Bank's 13F filing for Q2 2025, filed 4 Aug 2025.